Ocean Allyson J 4

What Happened
Ocean Allyson J, a director of NovoCure Ltd (NVCR), sold 2,945 shares on 2026-06-02 for a weighted average price of $15.77, generating roughly $46,445 in proceeds. The filing reports this as a sale (S) and the transaction was a sell-to-cover tied to the vesting of Restricted Stock Units, not a discretionary open‑market liquidation.

Key Details

• Transaction date: 2026-06-02; filing date: 2026-06-03 (filed timely).
• Shares sold: 2,945; weighted average sale price: $15.77; total proceeds ≈ $46,445.
• Price range across multiple trades: $15.65 to $15.88 (weighted average reported).
• Reason: Mandated "sell to cover" to satisfy tax withholding on RSU vesting (per issuer award agreement). This is not a discretionary sell.
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Transaction code: S (sale); footnotes F1 (tax withholding/sell-to-cover) and F2 (multiple trades/weighted avg).

Context
Sell-to-cover transactions are common when restricted shares vest and are used solely to meet tax obligations; they do not necessarily indicate the insider’s view of the company. For retail investors, purchases or discretionary sales generally convey more about insider sentiment than required tax-withholding sales.